Clinical trial
Irinotecan, Carboplatin, Bevacizumab, and Radiation Therapy in the Treatment of…
NCT00308529 · SCRI Development Innovations, LLC, Other · Completed
Key facts
| NCT number | NCT00308529 |
|---|---|
| Title | Irinotecan, Carboplatin, Bevacizumab, and Radiation Therapy in the Treatment of Limited Stage Small Cell Lung Cancer |
| Official title | Phase II Study of Irinotecan, Carboplatin, Bevacizumab, and Radiation Therapy in the Treatment of Patients With Limited Stage Small Cell Lung Cancer |
| Lead sponsor | SCRI Development Innovations, LLC, Other |
| Collaborators | Genentech, Inc. Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Carcinoma, Small Cell Lung, Lung Cancer |
| Intervention type | Drug, Procedure |
| Interventions | irinotecan, carboplatin, bevacizumab, Radiation Therapy |
| Enrollment | 55 |
| Start date | Mar 1, 2006 |
| Primary completion | Apr 1, 2007 |
| Completion | Jan 1, 2009 |
| First posted | Mar 29, 2006 |
| Last update posted | Jun 22, 2010 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: